What is Acadia Pharmaceuticals's EV / EBITDA?

Acadia Pharmaceuticals (ACAD) reported EV / EBITDA of 38.4× in Q1 2026.

How has Acadia Pharmaceuticals's EV / EBITDA changed year-over-year?

Acadia Pharmaceuticals's EV / EBITDA increased by 265.7% year-over-year, from 10.5× to 38.4×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Acadia Pharmaceuticals ACAD EV / EBITDA

EV / EBITDA at other companies

BiogenBIIB

11.2×+2.8×

Neurocrine BiosciencesNBIX

16.4×-5.2×

Catalyst PharmaceuticalCPRX

7.4×-1.4×

PTC TherapeuticsPTCT

86.6×+82.7×

TG TherapeuticsTGTX

37.5×-67.9×

Arrowhead ResearchARWR

27.4×—

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

enterprise value/ebitda=38.4×

Based on the most recent quarter.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's EV / EBITDA?: Acadia Pharmaceuticals (ACAD) reported EV / EBITDA of 38.4× in Q1 2026.
How has Acadia Pharmaceuticals's EV / EBITDA changed year-over-year?: Acadia Pharmaceuticals's EV / EBITDA increased by 265.7% year-over-year, from 10.5× to 38.4×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.